
Artificial Intelligence (AI) is gaining prominence in urology with potential applications in prostate cancer diagnosis, treatment planning, and risk assessment. While AI shows promise, it lacks extensive validation and clinical applicability. Regulations like the EU Commission's AI Act are being proposed to facilitate adoption. Collaboration between developers, doctors, and patients is essential to navigate ethical dilemmas, reduce bias, and build trust in AI. Explainable AI methods enhance trust by demystifying AI models. Urologists should embrace AI's potential, leading the way in shaping AI's role in medicine through effective regulation.
Like
Save
Share